hirsutanone and Small-Cell-Lung-Carcinoma

hirsutanone has been researched along with Small-Cell-Lung-Carcinoma* in 1 studies

Other Studies

1 other study(ies) available for hirsutanone and Small-Cell-Lung-Carcinoma

ArticleYear
Diarylheptanoids from the bark of black alder inhibit the growth of sensitive and multi-drug resistant non-small cell lung carcinoma cells.
    Phytochemistry, 2014, Volume: 97

    An extended study of minor diarylheptanoids from the bark of black alder has resulted in the isolation of twenty diarylheptanoids, ten of which have not previously been reported (14-18, 20-24). The structures and configurations of all compounds were elucidated by NMR, HRESIMS, UV, IR, and CD. The anti-cancer potency of twenty diarylheptanoids and four previously isolated compounds (7, 10, 12, 13) was investigated in human non-small cell lung carcinoma cell lines (sensitive and multi-drug resistant variants) as well as in normal human keratinocytes. Diarylheptanoids with a p-coumaroyl group, 14 and 18, platyphylloside (1), platyphyllonol-5-O-β-D-xylopyranoside (2), alnuside B (4) and hirsutenone (9) exhibited strong anti-cancer activity, considerably higher than diarylheptanoid curcumin, which served as a positive control. Compounds 4, 9, 14, and 18 displayed significant selectivity towards the cancer cells. Structure/activity analysis of twenty-four closely related diarylheptanoids revealed a high dependence of cytotoxic action on the presence of a carbonyl group at C-3. Substitution of a heptane chain on C-5 and a number of hydroxyl groups in the aromatic rings also emerged as a significant structural feature that influenced their cytotoxic potential.

    Topics: Alnus; Antineoplastic Agents, Phytogenic; Catechols; Cell Survival; Diarylheptanoids; Drug Screening Assays, Antitumor; Glycosides; Heptanes; Ilex; Nuclear Magnetic Resonance, Biomolecular; Plant Bark; Small Cell Lung Carcinoma

2014